What was studied?
Researchers compared three absorption enhancers using intestinal cell layers, rat experiments and selected large-animal formulations.
What did the researchers report?
The enhancers increased transport through different pathways. Lauroyl-l-carnitine showed a favorable transport and barrier-recovery balance within this comparison; uptake inhibition reduced its effect in rats.
What are the limits?
These were experimental delivery systems, not interchangeable oral products. Animal exposure and short-term barrier measurements do not establish clinical safety or equivalence of a catalog material.
Original editorial summary by Sulan Peptide. Based on the source abstract; consult the full paper for methods, analyses, funding and disclosures.